Biomab Egfr

Biomab Egfr Uses, Dosage, Side Effects, Food Interaction and all others data.

Table Of contents

• Biomab Egfr
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Biomab Egfr
Generic	Nimotuzumab
Nimotuzumab Other Names	Nimotuzumab
Weight	50mg
Type	Injection
Groups	Investigational
Therapeutic Class
Manufacturer	Biocon Ltd
Available Country	India
Last Updated:	September 19, 2023 at 7:00 am

Uses

Biomab Egfr is an EGFR-targeting monoclonal antibody used in the treatment of squamous cell carcinomas of the head and neck and glioblastomas.

Investigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.

Biomab Egfr is also used to associated treatment for these conditions: Advanced Head and Neck Cancer, Advanced Stage Head and Neck Cancer, Glioblastoma Multiforme (GBM), High Grade Glioma (HGG), Advanced Epithelial Tumor of the Head and Neck

Innovators Monograph

You find simplified version here Biomab Egfr